By the late 1950s, another cytotoxic agent melphalan became available and when combined with prednisone (a steroid which in isolation reduced M‐protein levels) was the first combination therapy to produce objective response in MM.155, 156. Here, MYOM2 is linked to Miyoshi myopathy.